MicroRNA-5106-based nanodelivery to enhance osteogenic differentiation and bone regeneration of bone mesenchymal stem cells through targeting of Gsk-3α

This work reports the intracellular delivery of miRNA-5106 into stem cells. The intracellular delivery could efficiently enhance the osteogenic differentiation and in vivo bone regeneration through the targeting the Gsk-3α signaling pathway.